Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

3.45
Delayed Data
As of Jul 31
 +0.21 / +6.48%
Today’s Change
1.74
Today|||52-Week Range
4.10
+50.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues4.9M4.8M5.7M1.4M
 
 
 
 
 
Depreciation And Amortization55.0K55.0K58.0K46.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.5M12.0M12.5M6.3M
 
 
 
 
 
Research And Development9.9M9.6M9.9M3.7M
 
 
 
 
 
Total Operating Expenses12.6M12.0M12.6M6.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.6M-7.2M-6.9M-5.0M
 
 
 
 
 
Extraordinary Credit615.0K2.9M267.0K465.0K
 
 
 
 
 
Extraordinary Charge0.00-531.0K--0.00
 
 
Other Expenses-4.0K-11.0K967.0K-39.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.0M-4.9M-5.7M-4.5M
 
 
 
 
 
Net Income-7.0M-4.9M-5.7M-4.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.0M21.1M21.5M22.7M
 
 
 
 
 
Shares To Calculate EPS Diluted15.0M21.1M21.5M22.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.23-$0.26-$0.20
 
 
 
 
 
EPS Diluted-$0.47-$0.23-$0.26-$0.20